Advertisement
"PD-L1 inhibitors have significantly changed oncology [but] only about 30% of patients with cancer benefit from the drugs."
These talks could represent a significant step toward modernizing regulatory science.
Hurricane Maria's impact led to delays in care and uncertainty for patients with cancer in Puerto Rico.
"It arises from an ageist assumption of frailty, incompetence, and dependence."
Dr. Andrew Hertler explains the FDA’s decision to narrow approvals for PD-1 inhibitors for stomach and esophageal cancers
An AI-based digital tool provided effective insulin dosage titration recommendations for inpatients with type 2 diabetes.
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.